Literature DB >> 12216089

Bilateral testicular germ cell tumors: twenty-year experience at M. D. Anderson Cancer Center.

Mingxin Che1, Pheroze Tamboli, Jae Y Ro, Dong Soo Park, Jung Sil Ro, Robert J Amato, Alberto G Ayala.   

Abstract

BACKGROUND: The incidence of testicular carcinoma in the United States has increased significantly over the last two decades. Germ cell tumors form the majority of malignant testicular tumors. With advances in diagnosis and therapeutic approaches, germ cell tumors are now highly sensitive to treatment, providing long-term survival. It has been speculated that the incidence of bilateral germ cell tumors may increase due to the improved survival of patients with unilateral germ cell tumors. In this report, the authors present a study of bilateral germ cell tumors of the testis in men who were treated at The University of Texas M. D. Anderson Cancer Center over a 20-year period with emphasis on their incidence, histologic features, and clinical features.
METHODS: Between 1978 and 1999, 2431 patients with testicular germ cell tumors were treated at The University of Texas M. D. Anderson Cancer Center. Among these, 24 patients with bilateral germ cell tumors were identified. Clinical records and all available pathology slides of the tumors were reviewed.
RESULTS: The overall incidence of bilateral germ cell tumors in the patients with testicular germ cell tumors was 1% (24 of 2431 patients). The incidence was 1.8% (14 of 776 patients) in patients with seminoma and 0.6% (10 of 1655 patients) in patients with nonseminomatous germ cell tumors. Patients with seminoma who were age </= 30 years at the time of initial diagnosis had a higher incidence of bilateral tumors compared with older men. Twenty of 24 patients with bilateral germ cell tumors had metachronous tumors, and 4 patients had synchronous tumors. Among the patients with metachronous tumors, 70% of second tumors occurred within 5 years; the longest interval between the first and second tumors was 15 years. The outcome of patients with bilateral germ cell tumors was excellent; only 1 of 24 patients died of metastatic disease.
CONCLUSIONS: The overall incidence of bilateral testicular germ cell tumors was 1% in patients who were treated at The University of Texas M. D. Anderson Cancer Center over the past two decades. The incidence of bilateral germ cell tumors was related to the histologic type of the initial tumor and to the patient's age at initial presentation in patients with seminoma. Thus, patients in the second or third decade of life who presented with seminomas as their initial tumor were more likely to develop a second germ cell tumor compared with patients in the fourth or fifth decade of life. These findings have potentially important implications for clinical management by identifying a population of patients with germ cell tumors who are at risk of developing a second tumor and also for studying risk factors of bilateral germ cell tumors of the testis. Copyright 2002 American Cancer Society.

Entities:  

Mesh:

Year:  2002        PMID: 12216089     DOI: 10.1002/cncr.10804

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  20 in total

1.  Testosterone Level in Testicular Cancer Patients after Chemotherapy.

Authors:  M Sarfraz; Y Ashraf; S Sajid; M A Ashraf
Journal:  West Indian Med J       Date:  2016-04-29       Impact factor: 0.171

2.  Bilateral testicular germ cell tumours: a single hospital experience.

Authors:  R Morales-Barrera; C Valverde; J Rodón; J Pérez; X Maldonado; C Suárez; E Trilla; J Carles
Journal:  Clin Transl Oncol       Date:  2010-04       Impact factor: 3.405

Review 3.  Organ-sparing approaches for testicular masses.

Authors:  Alvaro Zuniga; Nathan Lawrentschuk; Michael A S Jewett
Journal:  Nat Rev Urol       Date:  2010-08       Impact factor: 14.432

4.  Efficacy of routine follow-up after first-line treatment for testicular cancer.

Authors:  J R Spermon; J A Witjes; L A L M Kiemeney
Journal:  World J Urol       Date:  2004-09-21       Impact factor: 4.226

Review 5.  Bilateral testicular germ cell tumors.

Authors:  Haşmet Sarıcı; Onur Telli; Muzaffer Eroğlu
Journal:  Turk J Urol       Date:  2013-12

6.  A unique case of bilateral synchronous testicular tumor with concomitant bilateral diffuse intratubular germ cell neoplasia: testis sparing surgery and local radiotherapy.

Authors:  Mehmet B Yuksel; Bilal Gumus; Erdem Ozbek; Nalan Nese
Journal:  Curr Urol       Date:  2012-12-21

7.  Risk and prognostic significance of metachronous contralateral testicular germ cell tumours.

Authors:  M Schaapveld; A W van den Belt-Dusebout; J A Gietema; R de Wit; S Horenblas; J A Witjes; H J Hoekstra; L A L M Kiemeney; W J Louwman; G M Ouwens; B M P Aleman; F E van Leeuwen
Journal:  Br J Cancer       Date:  2012-10-11       Impact factor: 7.640

8.  Male infertility and androgen replacement therapy for subjects with bilateral testicular tumors.

Authors:  Toshiyasu Amano; Tetsuya Imao; Katsuro Takemae
Journal:  Reprod Med Biol       Date:  2013-11-05

9.  Adjuvant radiotherapy for synchronous bilateral testicular seminoma: a case report and a review of the pertinent literature.

Authors:  Daniel A Jones; Elizabeth C Ester; David Leavitt; Robert Sweet; Badrinath Konety; Gautam Jha; L Chinsoo Cho
Journal:  Case Rep Urol       Date:  2013-05-28

10.  Subjective quality of life and sexual functioning after germ-cell tumour therapy.

Authors:  M J Fegg; A Gerl; T C Vollmer; U Gruber; C Jost; S Meiler; W Hiddemann
Journal:  Br J Cancer       Date:  2003-12-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.